{"id":"W3029871260","doi":"10.1200/jco.2020.38.15_suppl.1091","title":"Veliparib (V) monotherapy (monoTx) following combination therapy with V + carboplatin/paclitaxel (CP) in patients with g<i>BRCA</i>-associated advanced breast cancer: Exploratory results from BROCADE3.","year":2020,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"AbbVie","keywords":"Medicine; Internal medicine; Veliparib; Breast cancer; Oncology; Carboplatin; Cancer; Discontinuation; PARP inhibitor; Progression-free survival; Urology; Chemotherapy; Cisplatin; Poly ADP ribose polymerase","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001059377,0.0004910434,0.0009675568,0.0002504493,0.000183275,0.0006130452,0.0004355786,0.0004049537,0.001789933],"category_scores_gemma":[0.0008601455,0.000299501,0.0009879863,0.0003817922,0.0003874562,0.0004569113,0.0002789983,0.001279416,0.0003367469],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001129112,"about_ca_system_score_gemma":0.0009422389,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001181028,"about_ca_topic_score_gemma":0.003967439,"domain_scores_codex":[0.999616,0.0002001835,0.00002247419,0.00006684366,0.00003093914,0.00006338089],"domain_scores_gemma":[0.9994588,0.000144191,0.000172776,0.00003728043,0.00001777653,0.0001691678],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.7492589,0.01652634,0.03516645,0.0009919958,0.002234957,0.0003192945,0.0002915625,0.005514855,0.0223035,0.000224411,0.002287934,0.1648798],"study_design_scores_gemma":[0.2129856,0.6827282,0.0851325,0.0001574334,0.002258075,0.0007433094,0.0001738085,0.004994031,0.005994123,0.0003908753,0.004387341,0.00005464487],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9973447,0.001309289,0.0001619176,0.00009788098,0.00001479607,0.0002339491,0.000345218,0.00001966328,0.000472672],"genre_scores_gemma":[0.9977432,0.0007479598,0.0003608212,0.000103664,0.00002337512,0.0001924314,0.0004417713,0.000005324441,0.0003813324],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001789933,"threshold_uncertainty_score":0.008192301,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07922342325583095,"score_gpt":0.392223272220946,"score_spread":0.312999848965115,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}